PHARMA MAR, S.A.
Last · MCE€83.20-0.25 (-0.30%)stale · yahoo · 136h ago
Market cap€1.4B17.3M sh
P/E · TTM25.8fwd 12.9 · eps 3.22
Beta0.43vs S&P 500
Div yield1.20%annual · TTM
52w range
€64.00€105.20
Volume3.0Ksession
| Revenue | €174.9M |
|---|---|
| Operating income | €6.5M |
| Net income | €26.1M |
| Free cash flow | €-9.0M |
| Operating margin | 3.7% |
| Net margin | 14.9% |
| Return on equity | 12.5% |
| Period | 2024 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2024-04-24
- Operating Cf Burn
- Rd Intensity High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Rd Intensity High — R&D/Revenue 62.8%
Upcoming earnings
4:30 PM UTC+1
Period
Sep 2026
Est. EPS
$0.01
Est. revenue
47.0M